Can you make autistic people less autistic? Neurotech International (ASX: NTI) believes so based on data published from their Phase II/III clinical trial of NTI-164 which aims to treat Autism Spectrum Disorder (ASD). ASD is a complex neurodevelopmental condition that can manifest in various ways. From challenges in social interactions, repetitive behaviours, and restricted interests,
Read More
Autism Spectrum Disorder (ASD) affects 1 in 150 Australians. Boys are 4 times more likely to have it than girls, and symptoms are noticeable at around 2-3 years of age. According to the Australian Institute of Health and Welfare, the number of people with ASD in Australia is increasing, providing an impetus for biopharmaceutical company
Read More
Furthering their expertise in the field of cannabinoid-based therapeutics, Zelira Therapeutics (ASX: ZLD) is set to tap into the oral care market with the launch of hemp derived toothpaste in the United States. The toothpaste formulation was created by Sprinjene CEO and Founder, Dr Sayed Abrahim who developed the oral care product which is gluten-free,
Read More
Audio technology company Nuheara Limited (ASX: NUH) has secured access to a major customer base following the registration of their smart hearing solutions under the National Disability Insurance Scheme (NDIS). This will provide Australians with access to almost the full range of Nuheara products, many of which will assist the 29% of NDIS participants who
Read More